Drug Interaction — ORE Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Metronidazole
A. Metronidazole should be avoided where a suitable alternative exists because it can enhance the effect of warfarin, raising the INR and bleeding risk. The UK metronidazole SmPC states that warfarin-type oral anticoagulant therapy may be potentiated; it advises monitoring prothrombin time and notes that warfarin dose reduction may be required. SDCEP similarly identifies metronidazole as a drug that may enhance warfarin anticoagulation. Phenoxymethylpenicillin is excluded by the patient's previous anaphylaxis, not by a warfarin interaction. Cefalexin is a poor choice following immediate penicillin hypersensitivity. Azithromycin and doxycycline can occasionally affect anticoagulant control, so INR awareness is prudent, but neither is as classically and directly associated with clinically important warfarin potentiation as metronidazole in this option set.
Reference: Electronic Medicines Compendium. Metronidazole 200 mg Tablets – Summary of Product Characteristics, section 4.5 (Interactions), 2024. https://www.medicines.org.uk/emc/product/12348/smpc